---
schema_version: "secwatch.filing_event.v1"
accession: "0001323885-23-000094"
form_type: "8-K"
ticker: "ATRC"
cik: "0001323885"
company_name: "AtriCure, Inc."
filed_at: "2023-07-25T23:59:59+00:00"
generated_at: "2026-06-13T02:55:21.958360+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# AtriCure Q2 revenue $100.9M (+19.4% YoY); net loss narrows to $5.1M, adjusted EBITDA positive $8.0M

## Summary
- Worldwide revenue $100.9M, up 19.4% YoY; U.S. $84.9M (+19.1%), international $16.0M (+20.7%).
- Net loss of $5.1M, improvement of $9.7M vs Q2 2022; EPS loss $0.11 vs $0.32.
- Gross margin 76.4%, up 130 bps YoY; adjusted EBITDA positive $8.0M, up from -$3.2M.
- FY 2023 guidance: revenue $392M-$395M (19-20% growth), adjusted EBITDA ~$12M positive.
- Adjusted loss per share guided at $0.92-$0.94 for full year 2023.

## SEC filing metadata
- accession: 0001323885-23-000094
- form_type: 8-K
- ticker: ATRC
- cik: 0001323885
- company_name: AtriCure, Inc.
- filed_at: 2023-07-25T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1323885/000132388523000094/0001323885-23-000094-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1323885/000132388523000094/atrc-20230725.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001323885-23-000094
- JSON: https://secwatch.observer/filing/0001323885-23-000094.json
- Plain text: https://secwatch.observer/filing/0001323885-23-000094.txt

## Key facts
- Earnings Releases
  AtriCure, Inc. reported the second quarter ended June 30, 2023 results: revenue $100.9 million, net income Net loss of $5.1 million, EPS $0.11. Guidance reaffirmed.
  - Period: the second quarter ended June 30, 2023
  - Revenue: $100.9 million
  - Net income: Net loss of $5.1 million
  - EPS: $0.11
  - Guidance: reaffirmed
  - Result: reported results
  source text: in any such filing or document. --- EX-99.1 (EX-99.1) --- For immediate release July 25, 2023 AtriCure Reports Second Quarter 2023 Financial Results • Worldwide revenue of $100.9 million – an increase of 19.4% year over year • U.S. revenue of $84.9 million – an increase of 19.1% year over year • International revenue of $16.0 million – an increase of 20.7% year
  evidence_url: https://www.sec.gov/Archives/edgar/data/1323885/000132388523000094/0001323885-23-000094-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.